Citation Formats
Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

K. Altundag Et Al. , "Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen," MEDICAL HYPOTHESES , vol.63, no.5, pp.823-826, 2004

Altundag, K. Et Al. 2004. Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen. MEDICAL HYPOTHESES , vol.63, no.5 , 823-826.

Altundag, K., Altundag, O., Gunduz, M., & Arun, B., (2004). Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen. MEDICAL HYPOTHESES , vol.63, no.5, 823-826.

Altundag, K Et Al. "Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen," MEDICAL HYPOTHESES , vol.63, no.5, 823-826, 2004

Altundag, K Et Al. "Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen." MEDICAL HYPOTHESES , vol.63, no.5, pp.823-826, 2004

Altundag, K. Et Al. (2004) . "Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen." MEDICAL HYPOTHESES , vol.63, no.5, pp.823-826.

@article{article, author={K Altundag Et Al. }, title={Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen}, journal={MEDICAL HYPOTHESES}, year=2004, pages={823-826} }